Trial · NCT06140485
A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
NCT06140485, Phase 3, Unknown, Natural Wellness Egypt
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus. Trials, record NCT06140485. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06140485
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
- NCT number
- NCT06140485
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 400 participants, estimated
- Lead sponsor
- Natural Wellness Egypt
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- NW Low-Glu®, Metformin
- First posted
- 2023-11-20
- Last updated
- 2023-11-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Comparing the mean change in HbA1c levels between the experimental arm and the active-control arm | 6 months | To compare the hypoglycemic effect of a herbal medicinal product (NW Low-Glu) to that of metformin as measured by the mean change in HbA1c levels in patients with type II diabetes mellitus. |
| Secondary | Comparing the mean change in HbA1c levels between the experimental arm and the active-control arm Comparing the mean change in fasting blood glucose levels | 6 months | To compare the hypoglycemic effect of a herbal medicinal product (NW Low-Glu) to that of metformin as measured by the mean change in fasting blood glucose levels in patients with type II diabetes mellitus. |
| Secondary | Measuring the incidence of AEs, SAEs, TEAEs, hypoglycemic events, and abnormal laboratory test findings in both the experimental arm and the active comparator arm | 6 months | To measure the incidence of adverse events (AEs), serious adverse events (SAEs), treatment-emergent adverse events (TEAEs), hypoglycemic events, and abnormal laboratory test findings in both the experimental arm and active comparator arm |
| Secondary | Assessing cardiovascular AEs in both the experimental arm and the active comparator arm | 6 months | To measure the number, nature, and severity of cardiovascular AEs and their causal relationship to the received intervention in both the experimental arm and active comparator arm |
| Secondary | Comparing the mean change in weight between the experimental arm and the active-control arm | 6 months | To compare the mean change in body weight between the experimental arm and the active comparator arm |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06140485
GET https://conductscience.org/api/trials/v1/NCT06140485/registered